Chanvida Broad Spectrum Bb Cream
NDC Package 84148-027-01
Package Information
Chanvida Broad Spectrum Bb Cream cream is 1. This formulation utilizes a cream delivery system. Marketed by Guangzhou Ariel Biotech Co., Ltd., this product is identified by NDC 84148-027 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
- 3-O-ETHYL ASCORBIC ACID 1 g/100g
- ACETYL HEXAPEPTIDE-8 .001 g/100g
- ACETYL TETRAPEPTIDE-5 .001 g/100g
- ALPHA-TOCOPHEROL ACETATE .5 g/100g
- DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE .001 g/100g
- GLYCYRRHIZA GLABRA (LICORICE) ROOT .01 g/100g
- NIACINAMIDE 2.5 g/100g
- RETINOL .01 g/100g
- SODIUM HYALURONATE .11 g/100g
- ZINC OXIDE 9.7 g/100g
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 84148 - Guangzhou Ariel Biotech Co., Ltd.
- 84148-027 - Chanvida Broad Spectrum Bb Cream
- 84148-027-01 - 50 g in 1 BOTTLE
- 84148-027 - Chanvida Broad Spectrum Bb Cream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84148-027-01 identifies a specific commercial package of 50 g in 1 bottle of Chanvida Broad Spectrum Bb Cream, a human over the counter drug labeled by Guangzhou Ariel Biotech Co., Ltd.. This cream is formulated for cutaneous use and contains 3-o-ethyl ascorbic acid; acetyl hexapeptide-8; acetyl tetrapeptide-5; alpha-tocopherol acetate; dipeptide diaminobutyroyl benzylamide diacetate; glycyrrhiza glabra (licorice) root; niacinamide; retinol; sodium hyaluronate; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Ariel Biotech Co., Ltd. on April 16, 2026. The current certification is valid through December 31, 2027.
How is this Guangzhou Ariel Biotech Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84148002701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.